Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
HIV InfectionsAIDSDyslipidemiaHypertriglyceridemia
Interventions
DRUG

Omega-3 fatty acid administration

LOVAZA 1 gram capsules, 4 capsules daily

DRUG

Placebo

Corn-oil placebo

Trial Locations (3)

20007

Georgetown University, Washington D.C.

21287

Johns Hopkins University, Baltimore

90073

Veterans Administration of Greater Los Angeles Health System, Los Angeles

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

collaborator

GlaxoSmithKline

INDUSTRY

lead

Brown, Todd, M.D., Ph.D.

INDIV

NCT00346697 - Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients | Biotech Hunter | Biotech Hunter